COMPUGEN LTD
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type other
SEC Category Accelerated filer
State of Incorporation Israel
Business Address 26 HAROKMIM STREET, HOLON, L3, 5885849
Mailing Address 26 HAROKMIM STREET, HOLON, L3, 5885849
Phone 011-972-3-765-8585
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
$35.34M
Net Income
$102.73M
Stockholders' Equity
$90.60M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
Annual Reports
20-F March 2, 2026
- Compugen's revenue significantly increased from $5 million to $15 million, driven by milestone payments and research funding from collaborations.
- Lead drug candidate, COM701, continued to advance in multiple Phase 1/2 clinical trials, showing promising signs of activity in solid tumors.
Insider Trading
SELL 1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
SANGAMO THERAPEUTICS, INC
SGMO Biological Products, (No Diagnostic Substances)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
EXOZYMES INC.
EXOZ Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.